AHRO - International Malaria Conference
   
   
     
     
 
 
Related Links
Program Line up
Call for Abstract
Registration
Scholarship
General Information
Sponsors & Exhibitors
Accommodation
Tour
 
 

The Africa Health Research Organization in conjunction with its partner under the sponsorship of Dafra Pharma International Ltd welcomes you to:

1 st AHRO International Malaria Symposium on Clinical Pharmacology of Antimalarial Drugs

Dates: 12-13 August 2008.

Programme Overview  

11th August MONDAY
Pre-symposium Events

10:00 am - 11:00 am Welcome Interactive Sessions

11:00 am - 16:00 pm Social Events: “ Take off the white coats
Tour includes visit to the Dzorwulu School of the Handicapped, Elmina Castle and Kwame Nkrumah Memorial Park .

16:00 pm - 17:00 pm  

Lectures by Dr Volker on Vaccine Strategies and Prof Nadira on Antimalarial resistance 

 

12th August, 2008 TUESDAY
7:30 am - 8:30 am Breakfast

AM  
  Opening Lectures: The Present Global Perspective

Chair: Professor Jean-Bosco Quegraogo(IRSS, Burkina Faso)

9:00 am - 9:15 am Welcome to Speech

9:15 am - 9:45 am Professor Boaz Adegboro (University Of Ilorin, Nigeria)
“Recent Advances in the treatment of Malaria Infection”

9:45 am - 10:15 am Dr James-Paul Kretchy (University of Ghana Medical School)
“Microvascular Damage, Variant Surface Antigens and Pathogenesis of Severe Malaria

10:15 am - 10.45 am Dr Ebenezer Inkoom (UNICEF, Ghana)
“Reducing Malaria –associated mortalities- role of effective treatment”

10:45 am - 11:15 am Dr Joaquim Sewaka (WHO Representative in Ghana)
“The burden of Malaria Drug resistance”

11:15 am - 11:30 am Coffee Break

  Session 1: Pharmacokinetics & Pharmacodynamics of Antimalarial Drugs

Chairperson: Professor Wilfred Mbacham (University of Yaoundé, Cameroon)


11:30 am - 12:00 nn

Dr FH Jansen (R&D Director, Dafra Pharma Ltd, Belgium )Resistance to Partner drugs in ACT's: A critical appraisal of the Paradox”

12:00 nn - 12:30 pm Dr Sergio Giani (Aids To Development Of Traditional Medicine, Mali) “Malaria & Traditional Medicine in Mali ”

12:30 pm - 13:00 pm

Dr I Ikeh (Ebonyi State University, Nigeria)
Assessment of the efficacy of synergistic combination of Pyrimethamine and Sulfadoxine (Maloxine) in Abakaliki Ebonyi State Nigeria”

13:00 pm - 13:30 pm Dr TF Muanda (University of Kinshasa, DRC)
“Assessment of rational use of ACT in Kinshasa, DRC”

13:30 pm - 14:00 pm Professor Issaka Sagara (University of Bamako)
“Typical African diets: fat content and absorption of artemether-lumefantrine”

14:00 pm - 14:30 pm Professor Larry Fleckenstein (University of Iowa, USA)
“Pharmacokinetic of Pyronaridine/ Artesunate (Pyramax): A new ACT”

14:30 pm - 15:00 pm Panel Discussion

15:00 pm - 16:30pm Lunch & Interactive session


PM

  Session 2 : Treatment of Complicated and Uncomplicated Malaria & Co-infections

Chair: Professor Hamza Babiker (University of Edinburgh , Scotland & Sultan Qaboos University, Oman)

17:00 pm – 17:30 pm Dr Jorgen Kurtzhals (University of Copenhagen, Denmark)
“Adjunct Treatment for Complicated Malaria: Past Disappointment, Future Promises”

17:30 pm -18:00 pm Dr TF Muanda (University of Kinshasa, DRC)
“Strategies for improving the use of ACT in the treatment of uncomplicated malaria in DRC”

18:00 pm – 18:30 pm Dr Catherine O Falade (University of Ibadan , Nigeria)
“IPT with SP As Effective Strategy To Prevent Maternal & Placental Malaria”

18:30pm - 19:00pm

Professor Wilfred Mbacham (University Of Yaoundé, Cameroun)
“Therapeutic efficacy of Fansider & Antifolate resistance gene in two ecological zones
In Cameroon”


19:00pm- 19:30pm Panel Discussion

19:30pm-19:45pm Coffee Break

  Session 3: Drug Combination & Interaction in Malaria

Chair: Professor Francine Ntoumi
(MIM Secretariat Co-coordinator, Tanzania)
 
19:45pm - 20:15pm Dr George Obeng Adjei (Korle-Bu Teaching Hospital, Ghana)
“Amodiaquine alone or in combination with Artesunate or co-arthemether: Efficacy Pharmacokinetics, safety and molecular markers in Children reporting to Korle-Bu Hospital”

20:15pm - 20:45pm

Dr FH Jansen (R&D Director, Dafra Pharma Ltd, Belgium )

“Fixed dose combination in the treatment of Malaria: Role of partner drug”

20:45pm - 21:15pm

Professor Ib C Bygberg ( University of Copenhagen , Denmark )

Taking Laboratory Research into Clinical & Public Health: The case of resistance and interactions of antimalarials”

21:15pm - 22:15pm Panel Discussion

22:15pm-22:30pm Closing Remark

22:30 pm First Day Closes

13th August, 2008 WEDNESDAY
AM

  Session 4: Drug Resistance

Chair: Professor Larry Fleckenstein (Iowa University, USA)

9:30 am - 10:00 am Professor AP Dash (National Malaria Institute of Research, India)
“Drug Resistance in India”

10:00am- 10:30am: Dr Olukemi Amodu (University of Ibadan)
“Ineffective Antimalarial is deleterious in the outcome of severe malaria”

10:30-10:45am Coffee Break

10:45am-11:15am

Professor Hamza Babiker (University of Edinburgh, Scotland & Sultan Qaboos University, Oman)
“Compromised Fitness of Drug Resistance Plasmodium Falciparum Parasites

11:15am- 11:45pm Dr Motalalepula G Matsabisa (Medical Research Council, South Africa)
“Chloroquine: In vitro Activities & Resistance Reversal”

11:45am-12:15pm Professor Jean-Bosco Ouegraogo (IRSS, Burkina Faso)
“ACTs and Recurrent Malaria Infection in West Africa”

12:15pm- 13:30pm Panel Discussion

13:30pm-14:30pm Lunch Break & Interactive Session

PM  
 

Satellite Meeting by Dafra Pharma International

Chair: Professor Nadira Karunaweera University of Colombo

14:30pm-15:30pm

Topic Confirmed

  Session 5: Clinical Trials

Chair: Professor Ib C Bygberg (University of Copenhagen, Denmark)
15:30pm – 16:00pm

Dr Charles Mutai (Kenya Medical Research Institute, Kenya)
“In vivo Screening of Antimalarial Activity of Acacia Mellifera (Leguminosae) on Plasmodium Berghei in mice

16:00pm-16:30pm

Dr Kolawole Olatunji (University of Ilorin)
“Antimalarial & Hematological Evaluation of Ethanolic Extracts of Cleodendrum violaceum”

16:30pm-17:00pm

Dr Jean-Francois Trape (Institut de Recherché pour de Development, Senegal)
Antimalarials and Malaria burden: Lesson from longitudinal studies””

17:00pm-17:30pm

Professor Wilfred Mbacham (University of Yaoundé, Cameroon)
“Managing Adverse Events & Effects during Malaria Trials”

17:30pm-18:00pm Professor Issaka Sagara (University of Bamako, Mali)
“Dispersible tablet formulation of artemether-lumefantrine (Coartem®): Efficacy and safety in paediatric patients with acute uncomplicated Plasmodium falciparum malaria – a randomized, investigator-blinded, multicenter comparison with the crushed tablet”

18:00pm – 18:45pm Panel Discussion”

18:45pm- 19:00pm Coffee Break & Interactive Session

 

Session 6: Vaccine Strategies

Chair: Professor Nadira Karunaweera ( University of Colombo , Sri Lanka )

19:00 am - 19:30 pm Dr Volker Heussler (Bernhard-nocht Institute, Germany)
“Plasmodium Survival Strategies & Pre-erythrocytic Vaccine Development”

19:30-20:00pm Godswill Anyasor (Babcock University, Nigeria)
“Artesunate opens rat liver mitochondrial membrane permeability (mmpt) pore”

20:00-20:30pm Dr Roma Chilengi (Malaria Network Trust)
“Malaria Vaccine for Africa-Experience of AMANET R&D”

20:30 pm – 21:00 pm Panel Discussion

21:00-21:10pm Vote of Thanks

21:10pm

Symposium Ends

Website last modified on 12 Feb2008
Copyright © AHRO, 2008. All rights reserved   Privacy Policy  |  Disclaimer  |  Link to Us